Denmark· DK-28106506420
Cibinqo
A abrocitinib product containing abrocitinib, registered in Denmark by Pfizer Europe MA EEIG. The same ATC class is registered in 15 of our 19 countries.
Checked against Danish Medicines Agency (Denmark) on
Informational only — not a medical device.
Where it is registered
Abrocitinib is registered in 15 of 19 countries.
Countries holding a registration under ATC D11AH08 (abrocitinib), each read from that country’s own register.
- This record: Denmark, from Danish Medicines Agency (Denmark)
- 9 of them publish a price we can compare per daily dose
Abrocitinib · ATC D11AH08
15 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Icelandprice
- Ireland
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of abrocitinib costs, country by country.
Normalised to the WHO defined daily dose (0.15 g), the median price runs from $0.26 in France to $122.11 in Switzerland — a ×472 gap.
- 2 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Abrocitinib · price per daily dose (0.15 g)
USD · FX 28 Sept 2026
- CH Switzerland$122.11
- FR France$0.26
The record
At a glance
Danish Medicines Agency (Denmark)- Active substance
- Abrocitinib
- Manufacturer
- Pfizer Europe MA EEIG
- Country
- Denmark (DK)
- ATC code
- D11AH08
- ATC class
- Abrocitinib
- Defined daily dose
- 0.15 g, O
- Reimbursed
- Not published by this register
- Source register
- Danish Medicines Agency (Denmark)
- Last checked
- September 30, 2026
Packs & prices · 1
- dk_varenummer28106506420
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same class
Other records under D11AH08
Abrocitinib, as other registers publish it.
- United StatesCibinqoPfizer Laboratories Div Pfizer Inc
- United StatesCibinqoPfizer Laboratories Div Pfizer Inc
- United StatesCibinqoPfizer Laboratories Div Pfizer Inc
- United StatesCibinqoPfizer Laboratories Div Pfizer Inc
- United StatesCibinqoPfizer Laboratories Div Pfizer Inc
- FinlandCibinqoPfizer Europe MA EEIG
- United StatesCibinqoPfizer Laboratories Div Pfizer Inc
- FinlandCibinqoPfizer Europe MA EEIG
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Danish Medicines Agency (Denmark). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/e843d505-0c9f-4008-a45e-295378150ba1 GET /v1/drugs/e843d505-0c9f-4008-a45e-295378150ba1?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "filmovertrukne tabletter",
"source": "dkma",
"strength": "200 mg",
"auth_role": "MOD",
"dk_drugid": "28106506420",
"substance": "Abrocitinib",
"auth_procedure": "Central",
"in_medicinpriser": true,
"registration_date_serial": "44539"
}See everything about abrocitinib.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.